
Organization · Venture Capital
Altitude Life Science Ventures
Altitude Life Science Ventures is an early-stage venture capital firm based in Kirkland, WA, focusing on life sciences investments, particularly in therapeutics and biotechnology. The firm has a notable track record of leading funding rounds and supporting innovative companies in the sector.
Overview
What Altitude Life Science Ventures does
What Altitude Life Science Ventures is
Altitude Life Science Ventures is an early-stage venture capital firm based in Kirkland, WA, focusing on life sciences investments, particularly in therapeutics and biotechnology. The firm has a notable track record of leading funding rounds and supporting innovative companies in the sector.
How it participates in the startup ecosystem
The current public profile supports funder and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2006
- Approximate age
- About 20 years
- Structured capabilities
- Funder · Publisher
- Last reviewed
- April 23, 2026
Official channels
Find Altitude Life Science Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Altitude Life Science Ventures as a funder
Investment thesis
Altitude Life Science Ventures focuses on early-stage life sciences investing, emphasizing therapeutics, biotechnology, and discovery tools in markets with significant demand and growth potential.
Focus narrative
The focus of Altitude Life Science Ventures is on early-stage investments in the life sciences sector. The firm aims to improve operational efficiency and reduce risk for its portfolio companies through strategic governance and AI advisory. By leveraging its expertise, Altitude Life Science Ventures seeks to enhance the value of its investments and drive growth in the life sciences industry.
Value beyond capital
Altitude Life Science Ventures adds value to its portfolio companies by providing strategic governance frameworks, technical risk and efficiency audits, and AI deployment strategies. The firm acts as a Technical Operating Partner, helping companies navigate operational challenges and enhance their growth trajectories.
Terms and economics
- Typical check
- $15,000,000–$40,000,000
Focus and fit
- Stages
- Seed · Series A · Series B · Series C
- Regions
- North America · Global
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- Illumina, Indigo, and Sana Biotechnology
Portfolio context
Altitude Life Science Ventures has a diverse portfolio that includes notable companies such as eFFECTOR Therapeutics, which raised $40M in Series B funding; Ring Therapeutics, which secured $86.5M in Series C funding; and Ansa Biotechnologies, known for its work in synthetic DNA. Other portfolio companies include Expedition Medicines and Lila Sciences, which focuses on AI and biotech discovery tools.
Capability profile
Altitude Life Science Ventures as a publisher
Editorial focus
Altitude Life Science Ventures focuses on improving operational efficiency and reducing risk for investment managers and operating companies. Their services include Technical Risk & Efficiency Audits, Fractional Technical Operating Partnerships, Strategic Governance & AI Advisory, Agentic AI Deployment, and Governance Engineering.
Audience value
Altitude Life Science Ventures aims to eliminate operational debt through the deployment of governance frameworks and Digital Workers, providing value to investment funds and complex enterprises.
Format and cadence
- Primary platform
- Website
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Fund Managers · Founders
- Regions
- North America · Global
Flagship work and coverage
Flagship properties
The organization publishes insights on governance, technology and tools, use cases, and leadership and culture through their website.
Notable coverage
Altitude Life Science Ventures has worked with notable clients such as J.P. Morgan, UBS, Deutsche Bank, and Morgan Stanley.
Connected ecosystem
Continue from Altitude Life Science Ventures
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Structured regional focus
Common questions
What to know about Altitude Life Science Ventures
Upseed classifies Altitude Life Science Ventures under the Venture Capital organization type. Its current public profile includes funder and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 23, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.